SP

Srinath Pandurangamurthy Vittalamurthy

Director Director DIN 07017550
DIN 07017550 First appointment Dec 2014 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinath Pandurangamurthy Vittalamurthy

Data last updated:

Srinath Pandurangamurthy Vittalamurthy was a Director at Medjons Pharmaceuticals Private Limited (2014–2016). The company operates in Healthcare.

DIN 07017550
Primary Designation Director
Industry Healthcare
First Appointment 09 Dec 2014

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Dec 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medjons Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srinath Pandurangamurthy Vittalamurthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinath Pandurangamurthy Vittalamurthy

Srinath Pandurangamurthy Vittalamurthy was first appointed on 09 Dec 2014 as Director at Medjons Pharmaceuticals Private Limited.

Srinath Pandurangamurthy Vittalamurthy held 1 earlier board appointment: Medjons Pharmaceuticals Private Limited (Director, 09 Dec 2014 to 19 Dec 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available